Resolution of inflammation: targeting GPCRs that interact with lipids and peptides
Open Access
- 1 August 2014
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 19 (8) , 1186-1192
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust
- Arthritis Research UK (19909)
- Sir Henry Wellcome Postdoctoral Fellowship (088967/Z/09/Z)
This publication has 83 references indexed in Scilit:
- n–3 Fatty Acids in Cardiovascular DiseaseNew England Journal of Medicine, 2011
- Chemokine-like receptor 1 (CMKLR1) and chemokine (C–C motif) receptor-like 2 (CCRL2); Two multifunctional receptors with unusual propertiesExperimental Cell Research, 2011
- Endogenous Galectin-1 and Acute InflammationThe American Journal of Pathology, 2011
- Resolvin D1 binds human phagocytes with evidence for proresolving receptorsProceedings of the National Academy of Sciences, 2010
- Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsisNature, 2009
- Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxisJournal of Experimental Medicine, 2008
- G Protein Activation by the Leukotriene B4 Receptor DimerJournal of Biological Chemistry, 2008
- Synthetic chemerin-derived peptides suppress inflammation through ChemR23Journal of Experimental Medicine, 2008
- The genetic design of signaling cascades to record receptor activationProceedings of the National Academy of Sciences, 2008
- Resolvin E1 and protectin D1 activate inflammation-resolution programmesNature, 2007